Chilton Investment Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,442
Closed -$2.25M 143
2017
Q3
$2.25M Sell
15,442
-61
-0.4% -$8.31K 0.09% 75
2017
Q2
$2.01M Buy
15,503
+61
+0.4% +$7.47K 0.08% 79
2017
Q1
$1.92M Sell
15,442
-62
-0.4% -$7.42K 0.07% 81
2016
Q4
$1.79M Buy
15,504
+62
+0.4% +$6.91K 0.07% 74
2016
Q3
$1.61M Buy
15,442
+950
+7% +$103K 0.06% 74
2016
Q2
$1.43M Hold
14,492
0.05% 86
2016
Q1
$1.45M Hold
14,492
0.05% 81
2015
Q4
$1.74M Buy
+14,492
New +$1.68M 0.06% 78
2015
Q1
Sell
-3,750
Closed -$419K 192
2014
Q4
$419K Buy
+3,750
New +$395K 0.01% 142

Other funds holding CELG

Chilton Investment Company's CELG Position: Q4 2017 in Review

Chilton Investment Company sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 15,442 shares — an estimated $2.25M sold.

Chilton Investment Company first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $2.25M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Chilton Investment Company reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Chilton Investment Company sold 15,442 Celgene Corp shares in Q4 2017, an estimated $2.25M.
  • Chilton Investment Company first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
  • Chilton Investment Company's Celgene Corp position peaked at $2.25M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Chilton Investment Company's 13F filing for Q4 2017, filed 7 Feb 2018.